iShares Biotechnology ETF (NASDAQ:IBB) Holdings Cut by JTC Employer Solutions Trustee Ltd

JTC Employer Solutions Trustee Ltd lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 23.9% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,214 shares of the financial services provider’s stock after selling 695 shares during the period. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $322,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of IBB. Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF in the first quarter worth about $27,000. Bbjs Financial Advisors LLC bought a new position in iShares Biotechnology ETF in the second quarter worth about $31,000. Pacifica Partners Inc. increased its stake in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares during the period. Mather Group LLC. acquired a new stake in shares of iShares Biotechnology ETF in the first quarter valued at approximately $57,000. Finally, Chris Bulman Inc acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $64,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $145.91 on Friday. The firm’s 50 day moving average is $145.65 and its two-hundred day moving average is $139.65. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.